INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
Prnewswire· 2025-06-15 23:20
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Iovance To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $100,000 in Iovance between August 8, 2024 and May 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 15, 2025 /PRNewswire/ -- ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Red Cat Holdings
Prnewswire· 2025-06-15 23:20
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Red Cat To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Red Cat between March 18, 2022 and January 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 15, 2025 /PRNewswire/ ...
Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results
Prnewswire· 2025-06-15 23:05
ALMATY, Kazakhstan, June 15, 2025 /PRNewswire/ -- Freedom Holding Corp. (NASDAQ: FRHC), the diversified financial group with operations spanning 22 countries, today reported financial results for the fiscal year ended March 31, 2025, highlighting continued growth across core segments and meaningful progress on its digital ecosystem strategy.Revenue for the year increased by 23% to $2.05 billion, up from $1.67 billion the previous year. The company delivered strong operational performance.Total assets increa ...
Oscar Health Could Be The Next Growth Monster With Tremendous Upside
Seeking Alpha· 2025-06-15 22:54
I am focused on growth and dividend income. My personal strategy revolves around setting myself up for an easy retirement by creating a portfolio which focuses on compounding dividend income and growth. Dividends are an intricate part of my strategy as I have structured my portfolio to have monthly dividend income which grows through dividend reinvestment and yearly increases. Feel free to reach out to me on Seeking AlphaAnalyst’s Disclosure:I/we have a beneficial long position in the shares of PLTR either ...
IBTA FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ibotta, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 16 Deadline in Securities Class Action First Filed by the Firm – IBTA
GlobeNewswire News Room· 2025-06-15 22:46
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ibotta, Inc. (NYSE: IBTA): (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Ibotta’s April 18, 2024 initial public offering (the “IPO”); or (2) between April 18, 2024 and February 26, 2025, inclusive (the “Class Period”), of the important June 16, 2025 lead plaintiff de ...
Private Equity For The People: 3 High-Yield BDCs Yielding Up To 13%
Forbes· 2025-06-15 22:45
Dark orange glowing wireframe bull on stock market diagram backgroundgettyLet’s invest like private equity pros without needing seven figures. Yes, that’s right—PE-style starting for as little as $8.Plus, yields up to nearly 13%.No special access or options trades needed. Just a few clicks through our brokerage accounts buying regular ol’ tickers.The sneaky dividend-dishing subjects? Meet business development companies (BDCs), publicly-traded firms that lend to small businesses.BDCs were invented by Congres ...
Iamgold: Stock's Success Is Likely To Continue
Seeking Alpha· 2025-06-15 22:45
David focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. He is a long term investor of quality stocks and uses options for strategy. David told investors to buy in March 2009 at the bottom of the financial crisis. The S&P 500 increased 367% and the Nasdaq increased 685% from 2009 through 2019. He wants to help make people money by investing in high-quality growth stocks.Analyst’s Disclosure:I/we have no stock, option or similar derivative p ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoubleVerify
Prnewswire· 2025-06-15 22:43
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In DoubleVerify To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $75,000 in DoubleVerify between November 10, 2023 and February 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, June 15, 202 ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals
Prnewswire· 2025-06-15 22:40
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $50,000 in Rocket Pharmaceuticals between February 27, 2025 and May 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YOR ...
WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WST
GlobeNewswire News Room· 2025-06-15 22:33
诉讼案件概述 - 罗森律师事务所提醒在2023年2月16日至2025年2月12日期间购买West Pharmaceutical Services公司普通股的投资者注意2025年7月7日的首席原告截止日期 [1] - 投资者可能有权通过应急费用安排获得补偿而无需支付任何自付费用 [2] - 首席原告是代表其他集体诉讼成员指导诉讼的代表方 [3] 律师事务所背景 - 罗森律师事务所在证券集体诉讼和股东衍生诉讼方面具有专长 [4] - 该事务所曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 2017年被ISS证券集体诉讼服务评为证券集体诉讼和解数量第一名 [4] - 自2013年以来每年排名前四 [4] - 2019年为投资者追回超过4.38亿美元 [4] 案件细节 - 指控West公司在整个诉讼期间做出虚假和误导性陈述或未能披露重要信息 [5] - West公司实际上正在经历其高利润率的高价值产品组合的持续去库存 [5] - SmartDose设备由于运营效率低下严重稀释了公司的利润率 [5] - 这些利润率压力导致公司可能退出与长期客户的连续血糖监测合同 [5] - 当真相公开后投资者遭受了损失 [5] 参与诉讼方式 - 投资者可通过网站、电话或电子邮件加入集体诉讼 [3][6] - 投资者可以选择自己的律师或保持缺席集体成员身份 [7] - 分享未来潜在赔偿的能力不取决于是否担任首席原告 [7]